Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SCYNEXIS (GB:0L49)
LSE:0L49
Holding GB:0L49?
Track your performance easily
0L49 Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.99 - $3.07
Previous CloseN/A
Volume178.00
Average Volume (3M)2.25K
Market Cap
$46.68M
Enterprise Value$19.08M
Total Cash (Recent Filing)$58.59M
Total Debt (Recent Filing)$14.25M
Price to Earnings (P/E)―
Beta3.22
Next Earnings
Mar 26, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding37,948,990
10 Day Avg. Volume3,483
30 Day Avg. Volume2,253
Standard Deviation1.15
R-Squared0.01
Alpha0.14
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.23
Price to Cash Flow (P/CF)14.60
P/FCF Ratio14.60
Enterprise Value/Market Cap0.41
Enterprise Value/Revenue4.21
Enterprise Value/Gross Profit0.15
Enterprise Value/Ebitda-1.17
Forecast
1Y Price Target
$8.00Price Target Upside595.65% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
SCYNEXIS News
PremiumPre-Earnings
Is SCYX a Buy, Before Earnings?
PremiumCompany Announcements
SCYNEXIS Advances Antifungal Treatments, Strengthens Financial Outlook
Options Prices
Currently, No data available
---
Ownership Overview
3.42% Insiders
24.14% Mutual Funds
0.04% Other Institutional Investors
56.35% Public Companies and Individual Investors
0L49 FAQ
What was SCYNEXIS’s price range in the past 12 months?
SCYNEXIS lowest share price was $0.98 and its highest was $3.07 in the past 12 months.
What is SCYNEXIS’s market cap?
SCYNEXIS’s market cap is $46.68M.
When is SCYNEXIS’s upcoming earnings report date?
SCYNEXIS’s upcoming earnings report date is Mar 26, 2025 which is in 70 days.
How were SCYNEXIS’s earnings last quarter?
SCYNEXIS released its earnings results on Nov 06, 2024. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.143 by $0.083.
Is SCYNEXIS overvalued?
According to Wall Street analysts SCYNEXIS’s price is currently Undervalued.
Does SCYNEXIS pay dividends?
SCYNEXIS does not currently pay dividends.
What is SCYNEXIS’s EPS estimate?
SCYNEXIS’s EPS estimate is -0.02.
How many shares outstanding does SCYNEXIS have?
SCYNEXIS has 37,948,990 shares outstanding.
What happened to SCYNEXIS’s price movement after its last earnings report?
SCYNEXIS reported an EPS of -$0.06 in its last earnings report, beating expectations of -$0.143. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of SCYNEXIS?
Currently, no hedge funds are holding shares in GB:0L49
---
SCYNEXIS Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (595.65% Upside)
$8.00 (595.65% Upside)
Blogger Sentiment
Bullish
GB:0L49 Sentiment 100%
Sector Average 71%
Sector Average 71%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.40%
12-Months-Change
Fundamentals
Return on Equity
-48.42%
Trailing 12-Months
Asset Growth
-33.33%
Trailing 12-Months
Company Description
SCYNEXIS
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
---
0L49 Company Deck
---
0L49 Earnings Call
Q4 2023
0:00 / 0:00
---
0L49 Stock 12 Month Forecast
Average Price Target
$8.00
▲(595.65% Upside)
Technical Analysis
SCYNEXIS
―
Chimerix
―
Karyopharm Therapeutics
―
Adaptimmune Therapeutics
―
ADMA Biologics
―
Inovio Pharmaceuticals
―
Sorrento Therapeutics
―
Best Analysts Covering 0L49
1 Year
1 Year Success Rate
5/38 ratings generated profit
1 Year Average Return
-26.36%
reiterated a buy rating 5 months ago
Copying Michael Higgins's trades and holding each position for 1 Year would result in 13.16% of your transactions generating a profit, with an average return of -26.36% per trade.
---